The 21st Annual Meeting of the American Society of Gene and Cell Therapy grew 31 percent and was the largest in group history.
MILWAUKEE (PRWEB) June 05, 2018
The 2018 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, held at the historic Hilton Chicago (May 16-19), was the Society's largest and most successful outing in the group's 21 year history.
The exciting growth in the premier annual event for gene and cell therapy professionals reflects the international buzz and excitement surrounding the field, in addition to the three historic FDA approvals of the first gene and cell therapies in the United States in the past year.
The expansion of ASGCT and the annual meeting runs parallel to the explosive growth of gene and cell therapy as a field:
ASGCT's 22nd Annual Meeting will be held in Washington D.C. at the Washington Hilton April 29 - May 2, 2019.
--
About The American Society of Gene & Cell Therapy
ASGCT is the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy. The Society’s mission is to advance knowledge, awareness, and education leading to discovery and clinical application of gene and cell therapies to alleviate disease. ASGCT’s vision is to serve as a catalyst to transform medicine by advancing gene and cell therapies to benefit patients and society.